Related Experiment Video
Updated: Jan 12, 2026

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
Published on: June 9, 2023
Alisol A Exerts Anti-Proliferative Activity against Human Oral Cancer Cells through Triggering JNK/p38 MAPK-Mediated
Yi-Tzu Chen1,2,3, Shao-Hsuan Kao4,5, Chun-Yi Chuang6,7
1School of Dentistry, Chung Shan Medical University, Taichung, 402, Taiwan.
Background:
Alisol A is a natural compound isolated from Alismatis Rhizoma, known for its diverse pharmacological activities, including anticancer and neuroprotective effects. This study aimed to explore the anticancer effects of Alisol A on oral cancer cells and elucidate its underlying mechanisms.
Methods:
Cell viability was measured by MTT assay, cell cycle by flow cytometry, and apoptosis by Annexin V/PI staining and caspase activation. Regulation of signaling pathways was analyzed using an apoptosis-related protein array, immunoblotting, and specific kinase inhibitors.
Results:
Alisol A reduced the viability of oral cancer cell lines, induced sub-G1 phase accumulation, and augmented the number of apoptotic cells. Protein array results indicated that Alisol A enhanced the expression of heme oxygenase-1 (HO-1), while suppressing cellular inhibitor of apoptosis protein 1 (cIAP1) and X-linked inhibitor of apoptosis protein (XIAP) levels in SCC-9 cells. These changes were further confirmed in both SCC-9 and HSC-3 cells by immunoblotting. In addition, Alisol A triggered the activation of caspase-8, -9, and -3, as well as poly (ADP-ribose) polymerase (PARP) cleavage in both cell lines. Analysis of signaling pathways showed that mitogen-activated protein kinases (MAPKs) were significantly activated by Alisol A. Notably, inhibition of JNK and p38 markedly reduced Alisol A-induced activation of caspase-8, -9, and -3.
Conclusions:
Our findings demonstrate that Alisol A exerts potent anticancer effects on oral cancer cells by inducing caspase-dependent apoptosis via activation of the JNK and p38 signaling pathways. These results suggest that Alisol A may have therapeutic potential for the treatment of oral cancer.
Insights
Alisol A, a natural compound, effectively combats oral cancer by inducing apoptosis through the JNK and p38 signaling pathways. This research highlights Alisol A
Area of Science:
- Pharmacology and Molecular Biology
- Natural Product Chemistry
- Cancer Research
Background:
- Alisol A, derived from Alismatis Rhizoma, possesses known anticancer and neuroprotective properties.
- Oral cancer remains a significant global health challenge, necessitating novel therapeutic strategies.
- Understanding the molecular mechanisms of natural compounds like Alisol A is crucial for drug development.
Purpose of the Study:
- To investigate the anticancer effects of Alisol A on oral cancer cell lines.
- To elucidate the underlying molecular mechanisms responsible for Alisol A's cytotoxic activity.
- To evaluate the therapeutic potential of Alisol A in oral cancer treatment.
Main Methods:
- Cell viability assessed via MTT assay.
- Cell cycle analysis conducted using flow cytometry.
- Apoptosis evaluated through Annexin V/PI staining and caspase activation assays.
- Signaling pathway analysis employed apoptosis-related protein arrays, immunoblotting, and kinase inhibitors.
Main Results:
- Alisol A significantly reduced oral cancer cell viability and induced apoptosis.
- Alisol A modulated apoptosis-related proteins, including HO-1, cIAP1, and XIAP.
- Activation of caspase-3, -8, -9, and PARP cleavage was observed.
- Alisol A activated MAPK pathways, specifically JNK and p38, which were critical for apoptosis induction.
Conclusions:
- Alisol A demonstrates potent anticancer activity against oral cancer cells.
- Apoptosis induction, mediated by caspase activation and JNK/p38 signaling, underlies Alisol A's efficacy.
- Alisol A shows promise as a potential therapeutic agent for oral cancer.
Related Concept Videos
The Intrinsic Apoptotic Pathway
Abnormal Proliferation
The Extrinsic Apoptotic Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Drugs that Stabilize Microtubules
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...